title: Acute oxygen-ozone administration to rats protects the heart from ischemia reperfusion infarct.
abstract: OBJECTIVE
  We tested here the effects of acute administration of an oxygen/ozone (O3) mixture on the myocardial tissue damage following an ischemic event.
  
  
  METHODS
  The study was done in Sprague-Dawley rats subjected to acute myocardial ischemia/reperfusion (I/R).
  
  
  METHODS
  100; 150; and 300 microg/kg oxygen/O3 mixture were insufflated intraperitoneally 1 h prior to I/R.
  
  
  METHODS
  Myocardial infarct size measurement and immunhistochemistry or ELISA for nitrotyrosine, CD68, CD8,CD4 and caspase-3 were done.
  
  
  RESULTS
  I/R produced a marked damage in the rat left ventricle with an infarct size as percentage of the area at risk (IS/ AR) of approximately 45 +/- 4% . Rats insufflated with a oxygen/O3 mixture showed a significant 2-h cardio-protection (e. g. infarct size over area at risk for the dose of 300 microg/kg was approximately 30 +/- 3%,) as compared with control rats (P <0.01). This effect was paralleled by a decrease in tissue levels of immunostaining for biomarkers of nitrosative stress (nitrotyrosine), inflammation (CD68) and immunity response (CD8 and CD4) between heart tissues from infarcted rats and infarcted O3 treated rats.
  
  
  CONCLUSIONS
  These data indicate that the tissue and biochemical damages associated with myocardial ischemia/reperfusion can be counteracted by an acute O3 pretreatment.
authors.affiliation: Department of Experimental Medicine, Section of Pharmacology "L. Donatelli", Second University of Naples, Via Costantinopoli 16, 80138 Naples, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Di Filippo
authors.forename: R
authors.initials: R
authors.lastname: Marfella
authors.forename: P
authors.initials: P
authors.lastname: Capodanno
authors.forename: F
authors.initials: F
authors.lastname: Ferraraccio
authors.forename: L
authors.initials: L
authors.lastname: Coppola
authors.forename: M
authors.initials: M
authors.lastname: Luongo
authors.forename: L
authors.initials: L
authors.lastname: Mascolo
authors.forename: C
authors.initials: C
authors.lastname: Luongo
authors.forename: A
authors.initials: A
authors.lastname: Capuano
authors.forename: F
authors.initials: F
authors.lastname: Rossi
authors.forename: M
authors.initials: M
authors.lastname: D'Amico
mesh_terms: D000818:Animals; D006321:Heart / Q000187:drug effects*; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy / Q000473:pathology / Q000517:prevention & control*; D017202:Myocardial Ischemia / Q000188:drug therapy*; D015428:Myocardial Reperfusion Injury / Q000517:prevention & control*; D010100:Oxygen / Q000494:pharmacology / Q000627:therapeutic use; D010126:Ozone / Q000494:pharmacology / Q000627:therapeutic use; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D010126:Ozone; D010100:Oxygen